Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

Clinical trial NCT06905834 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06905834
Sponsor: Instituto de Investigación Biomédica de Salamanca
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Disease (DED)Graft-Versus-Host Disease(GVHD)

Start date: 2026-05-01
Primary completion: 2027-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.